Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rifaximin for Immune Activation in HIV
NCT01466595Phase 2Completed
- Start
- Sep 2011
- Primary completion
- Sep 2012
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of rifaximin in human immunodeficiency virus infection (HIV). Started Sep 2011; status: completed.
02
Drugs
rifaximin
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT01466595.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01466595.